CN Stock MarketDetailed Quotes
002581 Shandong Sinobioway Biomedicine
- 12.62
- +0.12+0.96%
Not Open Nov 19 15:00 CST
8.33BMarket Cap-23946P/E (TTM)
12.68High12.13Low82.21KlotVolume12.50Open12.50Pre Close102.31MTurnover2.05%Turnover RatioLossP/E (Static)659.74MShares16.8652wk High3.98P/B5.06BFloat Cap7.7952wk Low13.75Limit Up400.79MShs Float71.85Historical High11.25Limit Down4.40%Amplitude4.39Historical Low--Dividend TTM12.44Avg Price43.02KlotAsk--Div YieldTTM100Lot Size36.83KlotBid
Shandong Sinobioway Biomedicine Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -6.99%314.71M | 0.77%210.78M | 10.85%83.8M | 20.36%429.79M | 22.80%338.35M | 11.47%209.17M | -13.49%75.6M | -11.33%357.08M | -12.75%275.53M | -16.35%187.64M |
| Operating revenue | -6.99%314.71M | 0.77%210.78M | 10.85%83.8M | 20.36%429.79M | 22.80%338.35M | 11.47%209.17M | -13.49%75.6M | -11.33%357.08M | -12.75%275.53M | -16.35%187.64M |
| Other operating revenue | ---- | -99.14%20.07K | ---- | 347.03%4.01M | ---- | 504.63%2.34M | ---- | -82.98%897.71K | ---- | -39.66%386.54K |
| Interest income | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
| Commission income | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
| Premiums earned | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
| Total operating cost | -19.08%348.2M | -16.82%235.97M | 1.75%106.36M | 12.37%610.72M | 2.39%430.32M | 4.41%283.69M | -17.51%104.54M | -11.55%543.47M | -6.65%420.28M | -15.05%271.7M |
| Operating cost | -2.46%62.19M | 2.28%40.78M | 14.18%16.65M | 9.43%83.39M | -0.67%63.75M | -15.28%39.87M | -47.64%14.58M | -11.21%76.21M | 2.48%64.19M | 6.70%47.06M |
| Operating tax surcharges | -4.47%4.89M | -2.26%3.27M | 60.35%1.55M | 6.66%6.89M | 17.96%5.11M | 1.95%3.35M | -18.16%966.55K | -5.46%6.46M | -8.04%4.34M | -8.05%3.28M |
| Operating expense | -10.66%190.66M | -6.02%128.15M | -5.99%46.81M | -1.43%288.3M | -8.57%213.42M | -5.59%136.36M | -17.68%49.79M | -15.31%292.48M | -16.62%233.42M | -25.98%144.44M |
| Administration expense | -27.25%74.21M | -25.03%52.56M | 26.61%35.43M | 23.39%165M | 9.30%102.01M | 13.44%70.11M | -8.17%27.98M | 0.99%133.73M | 19.15%93.33M | 8.79%61.8M |
| Financial expense | -120.61%-1.51M | -115.28%-801.96K | -109.61%-277.39K | 0.38%7.33M | 36.51%7.32M | 63.50%5.25M | 78.97%2.89M | 31.66%7.31M | 37.75%5.36M | 12.07%3.21M |
| -Interest expense (Financial expense) | ---- | ---- | ---- | -11.73%9.06M | ---- | ---- | ---- | 11.45%10.26M | --0 | ---- |
| -Interest Income (Financial expense) | ---- | ---- | ---- | 41.11%-1.78M | ---- | ---- | ---- | 19.43%-3.02M | --0 | ---- |
| Research and development | -54.11%17.76M | -58.24%12M | -25.45%6.21M | 119.13%59.8M | 96.98%38.7M | 141.50%28.74M | 62.29%8.33M | -29.01%27.29M | -5.17%19.65M | -31.43%11.9M |
| Credit Impairment Loss | 251.25%3.59M | 13.12%1.09M | 454.20%1.46M | 264.58%17.74M | -80.72%1.02M | -49.26%959.27K | -86.09%262.99K | 354.70%4.87M | 3,363.50%5.3M | 241.76%1.89M |
| Asset Impairment Loss | 105.09%424.23K | 105.09%424.23K | --424.23K | -2,069.03%-303.45M | ---8.33M | ---8.33M | ---- | ---13.99M | --0 | ---- |
| Other net revenue | -55.73%60.47M | -96.15%926.45K | -169.23%-5.39M | -151.09%-112.42M | -37.16%136.59M | -79.70%24.06M | -83.30%7.79M | -54.61%220.06M | -55.50%217.36M | -50.92%118.55M |
| Fair value change income | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
| Invest income | -59.08%58.96M | -91.77%2.97M | -201.77%-6.74M | -20.59%172.68M | -29.62%144.1M | -67.12%36.08M | -84.20%6.62M | -53.92%217.45M | -57.36%204.76M | -53.36%109.72M |
| Net open hedge income | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
| -Including: Investment income associates | ---- | ---- | ---- | -20.59%172.68M | ---- | ---- | ---- | -53.92%217.45M | --0 | ---- |
| Exchange income | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
| Asset deal income | 49.51%-3.31M | 27.11%-4.14M | -379.47%-814.39K | -12,388.97%-6.33M | -16,562.52%-6.55M | ---5.68M | --291.41K | 133.92%51.48K | ---39.3K | --0 |
| Other revenue | -87.45%797.38K | -43.24%589.44K | -53.80%281.69K | -40.70%6.93M | -13.49%6.36M | -85.02%1.04M | -78.48%609.76K | -21.63%11.68M | -12.98%7.35M | -9.13%6.93M |
| Operating profit | -39.54%26.98M | 51.93%-24.26M | -32.17%-27.95M | -971.22%-293.35M | -38.54%44.63M | -246.29%-50.46M | -389.71%-21.15M | -87.67%33.67M | -79.49%72.61M | -76.38%34.49M |
| Add:Non operating Income | 4,179.55%1.94M | 11,954.75%1.73M | 5,335.55%1.66M | 599.68%228.11K | -3.93%45.36K | -66.28%14.36K | -23.89%30.59K | -99.62%32.6K | -86.57%47.21K | -86.68%42.57K |
| Less:Non operating expense | -40.78%1.18M | -18.74%792.83K | 65.36%562.13K | -4.06%20.13M | 35.87%1.98M | 31.71%975.71K | 1,051.47%339.93K | 583.65%20.98M | 28.67%1.46M | -15.90%740.78K |
| Total profit | -35.00%27.74M | 54.65%-23.32M | -25.13%-26.85M | -2,561.76%-313.25M | -40.04%42.69M | -252.16%-51.42M | -393.52%-21.46M | -95.43%12.72M | -79.84%71.2M | -76.77%33.79M |
| Less:Income tax cost | -9.99%3.74M | 364.79%1.5M | 372.98%208.29K | -34.59%8.89M | 32.71%4.16M | -112.41%-564.75K | -103.00%-76.3K | 15,061.62%13.58M | 24.84%3.13M | 35.86%4.55M |
| Net profit | -37.70%24M | 51.20%-24.81M | -26.55%-27.06M | -37,415.86%-322.14M | -43.39%38.53M | -273.90%-50.85M | -548.17%-21.38M | -100.31%-858.66K | -80.59%68.06M | -79.43%29.24M |
| Net profit from continuing operation | -37.70%24M | 51.20%-24.81M | -26.55%-27.06M | -37,415.86%-322.14M | -43.39%38.53M | -273.90%-50.85M | -548.17%-21.38M | -100.31%-858.66K | -80.59%68.06M | -79.43%29.24M |
| Less:Minority Profit | 6.36%9.38M | 65.29%4.8M | 411.36%648.74K | -25.31%10.32M | 143.95%8.82M | -45.06%2.9M | -95.68%126.87K | 79.80%13.82M | 10.87%3.61M | 25.43%5.29M |
| Net profit of parent company owners | -50.78%14.63M | 44.91%-29.61M | -28.82%-27.7M | -2,164.66%-332.46M | -53.90%29.71M | -324.39%-53.76M | -1,272.29%-21.51M | -105.42%-14.68M | -81.45%64.45M | -82.63%23.96M |
| Earning per share | ||||||||||
| Basic earning per share | -50.67%0.0222 | 44.91%-0.0449 | -28.83%-0.042 | -2,159.64%-0.5039 | -53.94%0.045 | -324.52%-0.0815 | -1,264.29%-0.0326 | -105.43%-0.0223 | -81.45%0.0977 | -82.64%0.0363 |
| Diluted earning per share | -50.67%0.0222 | 44.91%-0.0449 | -28.83%-0.042 | -2,159.64%-0.5039 | -53.94%0.045 | -324.52%-0.0815 | -1,264.29%-0.0326 | -105.43%-0.0223 | -81.45%0.0977 | -82.64%0.0363 |
| Other composite income | ||||||||||
| Total composite income | -37.70%24M | 51.20%-24.81M | -26.55%-27.06M | -37,415.86%-322.14M | -43.39%38.53M | -273.90%-50.85M | -548.17%-21.38M | -100.31%-858.66K | -80.59%68.06M | -79.43%29.24M |
| Total composite income of parent company owners | -50.78%14.63M | 44.91%-29.61M | -28.82%-27.7M | -2,164.66%-332.46M | -53.90%29.71M | -324.39%-53.76M | -1,272.29%-21.51M | -105.42%-14.68M | -81.45%64.45M | -82.63%23.96M |
| Total composite income of minority owners | 6.36%9.38M | 65.29%4.8M | 411.36%648.74K | -25.31%10.32M | 143.95%8.82M | -45.06%2.9M | -95.68%126.87K | 79.80%13.82M | 10.87%3.61M | 25.43%5.29M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- |
| Auditor | -- | -- | -- | Shenzhen Guangshen Certified Public Accountants Firm (General Partnership) | -- | -- | -- | Shenzhen Guangshen Certified Public Accountants Firm (General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data